• Tue, February 15, 2022
• Wed, February 16, 2022
Tejas Savant Maintained (ADPT) at Hold with Decreased Target to $27 on, Feb 15th, 2022
Tejas Savant of Morgan Stanley, Maintained "Adaptive Biotechnologies Corporation" (ADPT) at Hold with Decreased Target from $46 to $27 on, Feb 15th, 2022.
Tejas, nor any peers, have made any analyst calls on ADPT in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30Like: 👍
